SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is capturing significant investor interest as part of a broader, government-backed quantum computing sector rally, with community sentiment shifting between optimism over potential policy catalysts and skepticism driven by continued insider selling and profitless financial performance. Investors are actively discussing the stock's role in the national quantum 'arms race' while closely watching technical levels and volume as they balance high-growth speculation against persistent volatility.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing heavy retail and institutional debate as the stock approaches its upcoming quarterly earnings report, with sentiment split between skepticism over short-term volatility and conviction in long-term platform growth. The community remains hyper-focused on management's guidance, interest rate impacts, and whether the stock will finally break its pattern of selling off despite strong operational performance.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors speculate on potential global expansion announcements and manufacturing updates ahead of an upcoming biotech conference. The community remains focused on the efficacy of Anktiva and active institutional accumulation, while some investors express frustration over a perceived quiet period and stock price volatility.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp (UAMY) is trending as retail investors rally around its status as a critical domestic antimony supplier amid heightened defense supply chain scrutiny, while the community actively debates whether current price action is the result of market manipulation or sector-wide volatility. Discussions are heavily focused on the company's government contracts, the strategic importance of domestic production for munitions, and the intense, polarized sentiment between long-term bulls and those concerned by recent downward price pressure.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is experiencing significant volatility and price swings as investors weigh stretched valuations against the company's long-term potential in AI-driven CPU architecture. The community remains deeply divided, with many traders debating whether recent price action is a healthy consolidation within a broader AI-infrastructure supercycle or a sign of a market bubble due to excessive leverage and analyst-driven hype.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors eagerly anticipate the release of Phase 3 IZAR-1 trial results, with many speculating this weekend as the potential window for the announcement. Community members are actively debating the timing of the readout and the potential for a significant valuation jump or buyout, while citing the company's strong institutional backing and the strategic value of its sonelokimab platform against industry incumbents.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently facing intense volatility as the market debates its high valuation against its long-term role as a backbone for AI and defense infrastructure. While the community remains sharply divided between bulls emphasizing massive growth potential in sovereign AI and skeptics pushing a bearish narrative due to macro headwinds and valuation concerns, the stock is seeing significant institutional attention heading into upcoming earnings.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is facing intense scrutiny as the market weighs the impact of aggressive AI capital expenditures alongside reports of layoffs in its AGI unit and a Senate investigation into its marketplace practices. Despite these headwinds, investors remain focused on its cloud growth and monetization potential ahead of earnings, while bullish sentiment is supported by strong options activity and recent price target upgrades from analysts.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Singapore.

Seagate Technology Holdings Plc

Seagate Technology (STX) is experiencing high volatility as investors react to mixed signals regarding the memory and storage cycle, with the community actively debating whether the stock's massive year-to-date gains are a structural breakout or a speculative bubble prone to a sharp reversal. Sentiment is polarized between long-term bulls highlighting critical AI-driven storage demand and skeptical traders pointing to heavy insider selling and technical indicators that suggest the shares may be overextended.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is facing a pivotal binary event as the FDA Advisory Committee convenes to review the Biologics License Application for deramiocel in Duchenne muscular dystrophy. The community is heavily focused on the potential for a dual-label approval, with investors debating the significance of labeling outcomes and the broader impact of ongoing patent litigation, while actively preparing for high volatility ahead of the scheduled review.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Filana Therapeutics Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.8909
Prev Close	$0.9322
Open	$0.9327
Dividend Yield	0.00%
50-Day Moving Average	$1.24
Beta	1.04
Avg. Volume	329,444.17
PE Ratio	-0.55

52-Week High	$4.98
52-Week Low	$0.89
Market Capitalization	$43.04M
EPS (Annual)	-$1.88
Price to Book	0.63
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

FLNAFilana Therapeutics Inc

Latest FLNA News